Cell Marque Portfolio

NKX3.1 (EP356)

Rabbit Monoclonal


NKX3.1 is a prostate specific androgen-regulated homeobox gene located on chromosome 8p.1-2  It is difficult to distinguish between high grade prostate adenocarcinoma and high grade infiltrating urothelial carcinoma using hematoxylin and eosin stained specimens.2 Current prostate adenocarcinoma markers such as prostate specific antigen (PSA) and prostate specific acid phosphatase (PSAP) are very useful in determining prostate origin of prostate cancer in other sites, but have lower sensitivity when identifying poorly differentiated compared to well differentiated cases.2 NKX3.1 is a sensitive and specific tissue marker of prostate adenocarcinoma and can be used to help distinguish it from urothelial carcinomas.1 Currently, thrombomodulin and uroplakin are used to identify tumors of urothelial origin; however, their sensitivities are suboptimal.2  NKX3.1 is a sensitive and specific tissue marker of prostate adenocarcinoma and can be used to help distinguish it from urothelial carcinomas as well as tumors of unknown primary.1

Specialties: Anatomic Pathology Genitourinary (GU) Pathology

Specifications


  • Reactivity: paraffin
  • Visualization: nuclear
  • Control: prostate adenocarcinoma, prostate
  • Isotype: IgG
  • Dilution Range: 1:50-1:200*

Protocols


  • Cell Marque HiDef
    T-PC/10-30minAb/HiDef/DAB
  • Cell Marque HiDef
    T-PC/10minAb/HiDef/Perm Red

Download an IFU

Select revision:


Keycode Specific IFU

Keycode:
Select prefix.
Please verify your keycode and try again. If problems presist contact Customer Service
Enter keycode.
Please verify your keycode and try again. If problems presist contact Customer Service

Some products may have special labeling requirements in the United States.

Are you located in the U.S.?



*Note: IFUs with the prefix RUO or ASR are only available for download in English.


Click here to learn about keycodes

Download SDS

References


  1. Gurel B, et al. NKX3.1 as a marker of prostatic origin in metastatic tumors. Am J Surg Pathol. 2010; 34:1097-105.
  2. Chuang AY, et al. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma. Am J Surg Pathol. 2007; 31:1246-55.

Last updated: 2017-05-24 08:46:09

NKX3.1
Nuclear labelling by anti-NKX3.1 on high-grade prostate carcinoma.

Mouse over to zoom, use scroll wheel to zoom in/out

Tap image once to activate zoom lens


Specifications


  • Reactivity: paraffin
  • Visualization: nuclear
  • Control: prostate adenocarcinoma, prostate
  • Isotype: IgG
  • Dilution Range: 1:50-1:200*

Protocols


  • Cell Marque HiDef
    T-PC/10-30minAb/HiDef/DAB
  • Cell Marque HiDef
    T-PC/10minAb/HiDef/Perm Red

References


  1. Gurel B, et al. NKX3.1 as a marker of prostatic origin in metastatic tumors. Am J Surg Pathol. 2010; 34:1097-105.
  2. Chuang AY, et al. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma. Am J Surg Pathol. 2007; 31:1246-55.

Download an IFU

Select revision:


Download SDS


Ordering Information

For in vitro diagnostic (IVD) use in USA

DescriptionCat. No.
0.1 ml, concentrate 441R-14
0.5 ml, concentrate 441R-15
1 ml, concentrate 441R-16
1 ml, predilute 441R-17
7 ml, predilute 441R-18
25 ml, predilute 441R-10

For in vitro diagnostic (IVD) use in Canada

DescriptionCat. No.
0.1 ml, concentrate 441R-14
0.5 ml, concentrate 441R-15
1 ml, concentrate 441R-16
1 ml, predilute 441R-17
7 ml, predilute 441R-18
25 ml, predilute 441R-10

For in vitro diagnostic (IVD) use in the EU

DescriptionCat. No.
0.1 ml, concentrate 441R-14
0.5 ml, concentrate 441R-15
1 ml, concentrate 441R-16
1 ml, predilute 441R-17
7 ml, predilute 441R-18
25 ml, predilute 441R-10

For research use only (RUO) in Japan

DescriptionCat. No.
0.1 ml, concentrate 441R-14-RUO
0.5 ml, concentrate 441R-15-RUO
1 ml, concentrate 441R-16-RUO
1 ml, predilute 441R-17-RUO
7 ml, predilute 441R-18-RUO
25 ml, predilute 441R-10-RUO

Specifications


  • Reactivity: paraffin
  • Visualization: nuclear
  • Control: prostate adenocarcinoma, prostate
  • Isotype: IgG
  • Dilution Range: 1:50-1:200*

Protocols


  • Cell Marque HiDef
    T-PC/10-30minAb/HiDef/DAB
  • Cell Marque HiDef
    T-PC/10minAb/HiDef/Perm Red

Download an IFU

Select revision:


Keycode Specific IFU

Keycode:
Select prefix.
Please verify your keycode and try again. If problems presist contact Customer Service
Enter keycode.
Please verify your keycode and try again. If problems presist contact Customer Service

Some products may have special labeling requirements in the United States.

Are you located in the U.S.?


*Note: IFUs with the prefix RUO or ASR are only available for download in English.



Click here to learn about keycodes

Download SDS

References


  1. Gurel B, et al. NKX3.1 as a marker of prostatic origin in metastatic tumors. Am J Surg Pathol. 2010; 34:1097-105.
  2. Chuang AY, et al. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma. Am J Surg Pathol. 2007; 31:1246-55.
Request More Information